Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Metastatic Urothelial Carcinoma
NCT01600339Phase 2Completed
- Sponsor
- Rambam Health Care Campus
- Start
- May 2012
- Primary completion
- Jan 2015
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in urothelial carcinoma (UC), sponsored by Rambam Health Care Campus. Started May 2012; status: completed.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01600339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01600339.